Zobrazeno 1 - 10
of 119
pro vyhledávání: '"M. Machnicki"'
Autor:
Wioleta Dudka, Grazyna Hoser, Shamba S. Mondal, Laura Turos-Korgul, Julian Swatler, Monika Kusio-Kobialka, Magdalena Wołczyk, Agata Klejman, Marta Brewinska-Olchowik, Agata Kominek, Milena Wiech, Marcin M. Machnicki, Ilona Seferynska, Tomasz Stoklosa, Katarzyna Piwocka
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-17 (2022)
Abstract The integrated stress response (ISR) facilitates cellular adaptation to unfavorable conditions by reprogramming the cellular response. ISR activation was reported in neurological disorders and solid tumors; however, the function of ISR and i
Externí odkaz:
https://doaj.org/article/33929fd1404a4b1cbcc53ea6d4fab9f9
Autor:
Aleksandra Bogucka-Fedorczuk, Anna Czyż, Andrzej Szuba, Marcin M. Machnicki, Monika Pępek, Rafał Płoski, Tomasz Stokłosa, Tomasz Wróbel
Publikováno v:
Central European Journal of Immunology, Vol 46, Iss 1, Pp 121-126 (2021)
Myeloproliferative neoplasms (MPNs) are a group of hematologic disorders characterized by clonal proliferation of myeloid lineage cells. The diagnostic criteria are based on morphological features of bone marrow and peripheral blood cells but also in
Externí odkaz:
https://doaj.org/article/3a8240da88ae467d919aaa66231a588b
Autor:
Marcin M. Machnicki, Anna Rzepakowska, Joanna I. Janowska, Monika Pepek, Alicja Krop, Katarzyna Pruszczyk, Piotr Stawinski, Malgorzata Rydzanicz, Jakub Grzybowski, Barbara Gornicka, Maciej Wnuk, Rafal Ploski, Ewa Osuch-Wojcikiewicz, Tomasz Stoklosa
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Hypopharyngeal cancer is a poorly characterized type of head and neck squamous cell carcinoma (HNSCC) with bleak prognosis and only few studies focusing specifically on the genomic profile of this type of cancer. We performed molecular profiling of 4
Externí odkaz:
https://doaj.org/article/b0077d933c8546e5bfad782da7cd1c51
Autor:
Tamara J. Blätte, Marcin M. Machnicki, Eliza Glodkowska-Mrowka, Anna Dolnik, Marta Karp, Agnieszka Karczmarczyk, Krzysztof Giannopoulos, Lars Bullinger, Tomasz Stoklosa
Publikováno v:
HemaSphere, Vol 5, Iss 1, p e514 (2021)
Externí odkaz:
https://doaj.org/article/c36dc612c2814e4b913ce176167a16c0
Autor:
Małgorzata Rydzanicz, Pawel Olszewski, Darek Kedra, Hanna Davies, Natalia Filipowicz, Bozena Bruhn‐Olszewska, Marco Cavalli, Krzysztof Szczałuba, Marlena Młynek, Marcin M. Machnicki, Piotr Stawiński, Grażyna Kostrzewa, Paweł Krajewski, Dariusz Śladowski, Krystyna Chrzanowska, Jan P. Dumanski, Rafał Płoski
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 9, Iss 1, Pp n/a-n/a (2021)
Abstract Background Phenotypically discordant monozygotic twins (PDMZTs) offer a unique opportunity to study post‐zygotic genetic variation and provide insights into the linkage between genotype and phenotype. We report a comprehensive analysis of
Externí odkaz:
https://doaj.org/article/853c2803d00245c78a246f0a79689b02
Autor:
Anna Deręgowska, Monika Pępek, Iwona Solarska, Marcin M. Machnicki, Katarzyna Pruszczyk, Marek Dudziński, Joanna Niesiobędzka-Krężel, Ilona Seferyńska, Waldemar Sawicki, Maciej Wnuk, Tomasz Stokłosa
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Purpose Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by recurrent genetic aberration in leukemic stem cells, namely Philadelphia chromosome caused by reciprocal translocation t(9;22)(q34;q11). In our study, we analyze
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::142310ff19bedc53f92869d03047c628
https://doi.org/10.1007/s00432-023-04662-w
https://doi.org/10.1007/s00432-023-04662-w
Autor:
Beata Pyrzynska, Michal Dwojak, Abdessamad Zerrouqi, Giulia Morlino, Piotr Zapala, Nina Miazek, Agnieszka Zagozdzon, Kamil Bojarczuk, Malgorzata Bobrowicz, Marta Siernicka, Marcin M. Machnicki, Stefania Gobessi, Joanna Barankiewicz, Ewa Lech-Maranda, Dimitar G. Efremov, Przemyslaw Juszczynski, Dinis Calado, Jakub Golab, Magdalena Winiarska
Publikováno v:
OncoImmunology, Vol 7, Iss 5 (2018)
Diminished overall survival rate of non-Hodgkin lymphoma (NHL) patients treated with a combination regimen of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) has been recently linked to recurrent somatic mutations activa
Externí odkaz:
https://doaj.org/article/ee1c3d0053564236a6f89f646c7e0906
Autor:
Bartosz Pula, Ewa Bodzenta, Dorota Zdunczyk, Małgorzata Rydzanicz, Iwona Sokolowska-Giezgala, Katarzyna Warzybok, Marcin M Machnicki, Magdalena Olszewska-Szopa, Anna Labedz, Jolanta Wieczorek, Dominika Wisniewska-Organek, Tomasz Stoklosa, Kamila Kruczkowska-Tarantowicz, Krzysztof Jamroziak, Marek Dudziński, Zofia Spyra-Gorny, Rafał Płoski, Dariusz Kumorek, Monika Pepek, Alina Urbanowicz, Elzbieta Morawiec-Szymonik, Agnieszka Szeremet, Pawel Bernatowicz, Agnieszka Pollak, Ryszard Wichary, Waldemar Tomczak
Publikováno v:
Acta Haematologica Polonica. 52:94-102
Indtroduction and methods: In chronic lymphocytic leukemia (CLL), molecular and cytogenetic diagnostics are crucial for the determination of accurate prognosis and treatment choice. Among different genetic aberrations, del(17p13) or TP53 mutations co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b29c879af395808b51a5c434c9bb48bf
https://doi.org/10.5603/ahp.2021.0015
https://doi.org/10.5603/ahp.2021.0015
Autor:
Tomasz Stoklosa, Rafał Płoski, Anna Czyż, Monika Pepek, Tomasz Wróbel, Andrzej Szuba, Marcin M Machnicki, Aleksandra Bogucka-Fedorczuk
Publikováno v:
Central European Journal of Immunology, Vol 46, Iss 1, Pp 121-126 (2021)
Central-European Journal of Immunology
Central-European Journal of Immunology
Myeloproliferative neoplasms (MPNs) are a group of hematologic disorders characterized by clonal proliferation of myeloid lineage cells. The diagnostic criteria are based on morphological features of bone marrow and peripheral blood cells but also in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20754eb2b31e629ad81a1b58b75fe106
https://www.termedia.pl/Co-occurrence-of-unclassified-myeloproliferative-neoplasm-and-giant-cell-arteritis-in-a-patient-treated-with-allogeneic-hematopoietic-stem-cell-transplantation-a-case-report-and-literature-review,10,35903,1,1.html
https://www.termedia.pl/Co-occurrence-of-unclassified-myeloproliferative-neoplasm-and-giant-cell-arteritis-in-a-patient-treated-with-allogeneic-hematopoietic-stem-cell-transplantation-a-case-report-and-literature-review,10,35903,1,1.html
Autor:
Maria Franaszczyk, Przemyslaw Chmielewski, Grazyna Truszkowska, Piotr Stawinski, Ewa Michalak, Malgorzata Rydzanicz, Malgorzata Sobieszczanska-Malek, Agnieszka Pollak, Justyna Szczygieł, Joanna Kosinska, Adam Parulski, Tomasz Stoklosa, Agnieszka Tarnowska, Marcin M Machnicki, Bogna Foss-Nieradko, Malgorzata Szperl, Agnieszka Sioma, Mariusz Kusmierczyk, Jacek Grzybowski, Tomasz Zielinski, Rafal Ploski, Zofia T Bilinska
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169007 (2017)
TTN gene truncating variants are common in dilated cardiomyopathy (DCM), although data on their clinical significance is still limited. We sought to examine the frequency of truncating variants in TTN in patients with DCM, including familial DCM (FDC
Externí odkaz:
https://doaj.org/article/a7449ce52b3946ebbf1c3eeabdef0c62